Biochemical and biological characterization of wild-type and ATPase-deficient Cockayne syndrome B repair protein by Citterio, E. (Elisabetta) et al.
Biochemical and Biological Characterization of Wild-type and
ATPase-deficient Cockayne Syndrome B Repair Protein*
(Received for publication, November 5, 1997)
Elisabetta Citterio, Suzanne Rademakers, Gijsbertus T. J. van der Horst, Alain J. van Gool‡,
Jan H.J. Hoeijmakers§, and Wim Vermeulen
From the Medical Genetics Centre Department of Cell Biology and Genetics, Erasmus University Rotterdam,
P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands
Cockayne syndrome (CS) is a nucleotide excision re-
pair disorder characterized by sun (UV) sensitivity and
severe developmental problems. Two genes have been
shown to be involved: CSA and CSB. Both proteins play
an essential role in preferential repair of transcription-
blocking lesions from active genes. In this study we re-
port the purification and characterization of baculovi-
rus-produced HA-His6-tagged CSB protein (dtCSB),
using a highly efficient three-step purification protocol.
Microinjection of dtCSB protein in CS-B fibroblasts
shows that it is biologically functional in vivo. dtCSB
exhibits DNA-dependent ATPase activity, stimulated by
naked as well as nucleosomal DNA. Using structurally
defined DNA oligonucleotides, we show that double-
stranded DNA and double-stranded DNA with partial
single-stranded character but not true single-stranded
DNA act as efficient cofactors for CSB ATPase activity.
Using a variety of substrates, no overt DNA unwinding
by dtCSB could be detected, as found with other SNF2/
SWI2 family proteins. By site-directed mutagenesis the
invariant lysine residue in the NTP-binding motif of
CSB was substituted with a physicochemically related
arginine. As expected, this mutation abolished ATPase
activity. Surprisingly, the mutant protein was neverthe-
less able to partially rescue the defect in recovery of
RNA synthesis after UV upon microinjection in CS-B
fibroblasts. These results indicate that integrity of the
conserved nucleotide-binding domain is important for
the in vivo function of CSB but that also other properties
independent from ATP hydrolysis may contribute to
CSB biological functions.
Nucleotide excision repair (NER)1 is an evolutionary
strongly conserved pathway responsible for the removal of a
wide variety of lesions from the DNA, including the major types
of UV-induced DNA injuries: cyclobutane pyrimidine dimers
and (6–4) photo products. Removal of these lesions proceeds
via a multi-step reaction; lesion recognition is followed by local
opening of the DNA helix, dual incision in the damaged strand
on each side of the lesion, release of the damage-containing
fragment, gap-filling DNA synthesis, and ligation. A large
number of gene products is involved in this repair reaction
(reviewed in Refs. 1–3). The dramatic consequences of impaired
NER are illustrated by several hereditary human diseases
including xeroderma pigmentosum (XP) and Cockayne syn-
drome (CS). Patients with XP manifest a high sun (UV) skin
sensitivity associated with a strong predisposition to skin can-
cer and frequently progressive neurodegeneration. Besides
these common features, a significant clinical and genetic het-
erogeneity is observed among XP patients. Seven excision-
deficient complementation groups (XP-A to XP-G) have been
identified so far on the basis of cell fusion experiments (4).
Patients with CS show, like XP, increased sensitivity to UV
light. In addition, they suffer from severe developmental prob-
lems, which include growth retardation, skeletal and retinal
abnormalities, and severe neurological deficiencies due to dys-
myelination of neurons (4–6). Unlike XP patients and unlike a
recently generated mouse model for CSB (7), no significant skin
cancer predisposition has been noted for CS so far.
Several observations have revealed functional connections
between DNA repair and basal transcription. Firstly, at least
three subunits of the basal transcription factor TFIIH (XPB,
XPD, and TTDA) are also required for NER (8–10). Secondly,
lesions in the transcribed strand of active genes hamper or
block the vital process of transcription. For some lesions such
as cyclobutane pyrimidine dimers the normal (global genome)
NER pathway is very slow. Therefore, a special subpathway of
NER has evolved that accomplishes rapid and efficient removal
of these types of damage from the transcribed strand of active
genes (11, 12). This process, called transcription-coupled repair
is highly conserved in evolution, because it has been described
in Escherichia coli, yeast and mammalian cells (7, 13–16). In
humans, two genes have been shown to be specifically required
for transcription-coupled repair: CSA and CSB, defective in CS
complementation groups A and B, respectively (17, 18). CS cells
exhibit an elevated UV sensitivity correlated with a specific
defect in transcription-coupled repair. Consequently, unlike
normal cells, they are unable to recover RNA synthesis after
UV irradiation (19, 20).
The CSB gene encodes a protein of 1493 amino acids con-
taining a 500-amino acid region highly homologous to members
of the SWI2/SNF2 subfamily of DNA-dependent ATPases (18,
21). Interestingly, SNF2-related proteins are involved in a wide
variety of cellular functions, notably transcription regulation,
chromatin remodelling, and all known multi-step DNA repair
pathways, such as nucleotide excision repair of both tran-
scribed and nontranscribed regions of the genome, post repli-
cation repair, and recombination repair (22, 23). Importantly,
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we found recently that the CSB protein resides in a large
molecular weight complex that includes RNA polymerase II but
no transcription initiation factors (24).
The mechanism by which CSB protein mediates transcrip-
tion-coupled repair is still largely unknown. Availability of a
recombinant CSB protein is essential for studying CSB activity
in in vitro assays. Here we present the generation, purification,
and functional characterization of a double-tagged wt and
ATPase-deficient mutant CSB protein. Surprisingly, the DNA-
dependent ATPase activity was found to be partially dispensa-
ble for the in vivo CSB function in RNA synthesis recovery.
EXPERIMENTAL PROCEDURES
Cell Culture—The immortalized human cell lines used in this study
were: HeLa, C5RO (wt), GM2965 (CS-A), CS1AN (CS-B), and
XPCS1BA(XP-B). The fibroblasts were cultured in Ham’s F-10 medium,
supplemented with antibiotics and 12% fetal calf serum. Cell-free ex-
tract from HeLa cells was prepared as described previously (25, 26).
An insect cell line, Spodoptera frugiperda Sf21, was cultured at 27 °C
in Hanks’ medium supplemented with antibiotics and 10% fetal calf
serum. Hanks’ medium was prepared from Grace’s insect cell culture
medium (Life Technologies, Inc.) supplemented with 0.33% tissue cul-
ture yeastolate (Difco), 0.33% tissue culture lactalbumin hydrolysate
(Difco), and 0.55% bovine serum albumin.
Plasmid Constructs—Previously we have generated a CSB cDNA
construct (2tpSLME6) encoding a N-terminal hemagglutinin antigen
(HA) epitope as well as a C-terminal histidine (His6) tag (24). For
overexpression of the HA-CSB-His6 in the BAC to BAC Baculovirus
Overexpression System (Life Technologies, Inc.), the N-terminal SacI
fragment and the C-terminal SacI-XbaI fragment were cloned together
in the pFASTBAC vector (Life Technologies, Inc.), giving rise to con-
struct 2tpFBACE6. Construct 2tpFBACE6-K538R, containing a muta-
tion changing the Lys-538 codon to Arg, was generated as described
below.
Site-directed Mutagenesis—The K538R mutation in the CSB cDNA
was introduced using the PCR-mediated site-directed mutagenesis
method (27). For this purpose, two fragments of the CSB cDNA con-
taining the helicase domain (1330-base pair KpnI-SmaI fragment and
1914-base pair KpnI-KpnI fragment) were independently subcloned
into pBluescript KS and pTZ18 vector, respectively. The primers used
in the PCR reactions are: the mutagenic primer (59 GGATTGGGCAG-
GACCATCCAG 39) and the universal primers SK and M13 universal.
The final PCR product was cloned into the pBluescript vector, and the
internal AsuII fragment was used to replace the wild-type fragment in
2tpFASTBACE6. Sequencing of the entire PCR fragment ruled out
PCR-derived errors and confirmed the presence of the desired mutation.
Baculovirus Infection and Purification of Recombinant Proteins—
Suspension cultures of Sf21 cells at 1.5 3 106 cells/ml were infected
with the recombinant baculoviruses at 27 °C for 1 h at a multiplicity of
infection of 5–10. At 3 days post-infection, cells were collected and
washed twice with ice-cold phosphate-buffered saline. For fraction-
ation, the cell pellet was resuspended into 8 (packed cell) volumes of
ice-cold NP lysis buffer (25 mM Tris-HCl, pH 9.0, 1 mM EDTA, 10%
glycerol, 1% Nonidet P-40, 0.3 M KCl, 1 mM dithiothreitol, 0,1 mM
phenylmethylsulfonyl fluoride, 0,2 mM chemostatin, leupeptin, anti-
pain, and pepstatin A). After incubation on ice for 30 min with occa-
sional agitation, the suspension was centrifuged at 12,000 3 g for 15
min to obtain the supernatant fraction and the precipitate fraction. To
examine the protein remaining in the precipitate fraction, the pellets
were homogenized in NP buffer by sonication. For purification, the
supernatant fraction was diluted with NP buffer at pH 6,8 in a 1:1 ratio
and loaded on a heparin-Sepharose (CL-6B; Amersham Pharmacia
Biotech) column equilibrated with buffer A (25 mM HEPES-KOH, pH 7,
9, 0,01% Nonidet P-40, 10% glycerol, 1 mM b-mercaptoethanol, 0, 1 mM
phenylmethylsulfonyl fluoride) containing 0.3 M KCl. The column was
washed with the same buffer, and the adsorbed proteins were eluted
with buffer A containing 0.8 M KCl. The eluate was directly loaded on a
Ni21-nitrilotriacetic acid-agarose column equilibrated with buffer A
containing 0.8 M KCl and 5 mM imidazole. After washing the column
with 20 mM Imidazole, bound proteins were eluted with buffer A con-
taining 0.3 M KCl and 60 mM/250 mM imidazole.
In the final step of purification, the Ni21-nitrilotriacetic acid elution
fractions were incubated with a 5-fold excess of monoclonal anti-HA
(12CA5) antibody O/N at 4 °C with rotation. The protein-antibody com-
plexes were subsequently bound to protein G-Sepharose beads. After
extensive washing of the beads with buffer A containing 0,1% Nonidet
P-40, CSB protein was specifically eluted using the synthetic HA pep-
tide (YPYDVPDYA) at 1 mg/ml in buffer A containing 0.2 M KCl.
Proteins were stored at 280 °C. The behavior of the recombinant pro-
tein during the purification was monitored by SDS-PAGE and immu-
noblot blot analysis.
ATPase Assay—Standard reactions (10 ml) were carried out in buffer
B (20 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 40 mg/ml bovine serum
albumin, 1 mM dithiothreitol), 1 mCi of [g-32P]ATP (5000 Ci/mmol;
Amersham Pharmacia Biotech) and the specified amounts of CSB pro-
tein. When indicated, reactions were carried out in the same buffer B
supplemented with 50 mM cold ATP and 0.25 mCi of [g-32P]ATP. 150 ng
of DNA cofactor/reaction was added. After 1 h at 30 °C the reactions
were stopped with 5 ml of 0.5 M EDTA, and a 1-ml sample was analyzed
on polyethylenimine-cellulose thin layer chromatography plates devel-
oped in 0.75 M KH2PO4. The extent of ATP hydrolysis was determined
by image analysis and quantification on a PhosphorImager (Molecular
Dynamics).
Helicase Assay—The partial duplex DNA substrates were con-
structed by hybridizing a 59 32P-labeled complementary fragment to the
viral (1)-strand of M13 DNA: (i) 18-base oligonucleotide; (ii) 36-base
oligonucleotide; (iii) 50-base oligonucleotide with a 59 15-base non-
complementary overhang; and (iv) 50-base oligonucleotide with a 39
15-base noncomplementary overhang. Helicase substrates with a 59-39
and a 39-59 polarity were made by hybridizing a 59-32P-labeled comple-
mentary fragment to a 36-base oligonucleotide (F36), respectively: (i)
19-base oligonucleotide (F19) and (ii) 17-base oligonucleotide (F17) (see
Table I). Also, a double-stranded 75-base DNA fragment was used. Free
oligonucleotides were removed by gel filtration on a Sephadex G50
(Amersham Pharmacia Biotech) column. The substrates, 5 ng each,
were incubated with the indicated amount of CSB protein in buffer B
containing 1 mM ATP (total volume 25 ml). After incubation at 37 °C for
45 min, reactions were stopped and subjected to electrophoresis on 12%
polyacrylamide gel and autoradiography as described (8).
Microneedle Injection of Recombinant Proteins and Analysis of Re-
pair and Transcription Levels—Microneedle injection into cultured fi-
broblasts was performed as described previously (10, 28). Comparable
amounts of purified recombinant CSB, wild type, and K538R mutant
dissolved at 20 ng/ml were injected into the cytoplasm of CS1AN (CS-B)
homopolykaryons (obtained after cell fusion of CS1AN (CS-B) fibro-
blasts with each other), multinucleated cells of GM2965 (CS-A), or
XPCS1BA (XP-B) homopolykaryons. The recovery of RNA synthesis
post-UV was measured. Cells were UV-irradiated with 10 or 15 J/m2
(UV-C 254 nm) and allowed to recover for 16–20 h. RNA synthesis was
measured after pulse-labeling with [3H]uridine (10 mCi/ml; specific
activity, 50 Ci/mmol), fixation, and autoradiography. Grains above the
nuclei of injected cells (polykaryons) and noninjected neighboring cells
(monokaryons) were counted and represent a quantitative measure for
RNA synthesis.
Antibodies—Anti-CSB antibodies used in this study were raised
against the C-terminal 158 amino acids of CSB. Characterization of
affinity-purified anti-CSB and immunoblotting procedures were per-
formed as described (24).
DNA Substrates—DNA cofactors used in the ATPase assay are de-
scribed in Table I and kindly provided by Wouter de Laat (29). HeLa
polynucleosomes were a generous gift of Robert Kingston and Gavin
Schnitzler.
RESULTS
Overexpression and Purification of Recombinant wt and Mu-
tant CSB Proteins—To facilitate purification of CSB and to
allow isolation of a full-length protein, we generated a double-
tagged CSB (dtCSB) construct (24) in a baculovirus expression
system. A 9-amino acid HA epitope was introduced at the N
terminus of the cDNA sequence, and a hexameric histidine
stretch (His6) was introduced at the C terminus. It was impor-
tant to verify whether the addition of tags per se did not
interfere with the biological function of CSB. Therefore, we
established by cDNA transfection a CS-B cell line stably ex-
pressing dtCSB in a mammalian expression vector. The level of
expression of dtCSB protein was similar to the endogenous
CSB level in normal cells. We found that the tagged protein
conferred wild-type UV resistance to the CS-B cells and was
incorporated into a large complex including RNA polymerase II
(see Ref. 24). Thus, these findings confirm that dtCSB was
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biologically active in vivo and functionally indistinguishable
from the untagged wt protein.
To investigate the importance of the ATPase activity for the
various CSB functions we introduced by site-directed mutagen-
esis a strategic amino acid substitution in the Walker-type A
motif (30) by replacing the invariant lysine residue (Lys-538) in
the GXGKT sequence by the physicochemically related argi-
nine, yielding dtCSB (K538R). It has been shown for other
ATPases that such an alteration does prevent ATP hydrolysis
but still permits ATP binding (31–33). Importantly, this con-
servative amino acid change is not expected to drastically mod-
ify the overall protein conformation.
Both the wild-type and the mutant CSB protein were over-
produced using the baculovirus/Sf21 insect cell system. In-
fected Sf21 cells were extracted with hypertonic buffer contain-
ing 0.3 M KCl, and the dtCSB protein was isolated from the
soluble fraction. The purification was monitored by immuno-
blot analysis using polyclonal anti-CSB antibodies and by sil-
ver staining of SDS-PAGE. After two chromatographic steps, a
heparin-Sepharose and a Ni21-nitrilotriacetic acid-agarose col-
umn that selects for the C-terminal His6 stretch, we obtained a
protein fraction consisting of a major band of about 170 kDa,
corresponding to the predicted molecular weight of dtCSB (Fig.
1, A and B, lanes 1–3). Some degradation products were visible
after immunoblot analysis using antibodies raised against the
C terminus of CSB (data not shown; similar findings made by
Selby and Sancar (34)). The presence of an HA epitope at the N
terminus of dtCSB allowed us to select only for full-length
protein during the last highly specific monoclonal affinity pu-
rification step. When the final fraction was analyzed by SDS-
PAGE and silver staining, no protein species other than dtCSB
were detected, indicating that the protein was purified to near
homogeneity (Fig. 1B, lane 4). The same purification procedure
was used for both wild-type dtCSB and dtCSB (K538R) mutant,
obtaining both proteins at comparable high levels of purity,
intactness, concentration, and yield (Fig. 1C). The three-step
purification scheme described above yielded about 22 mg of
protein from 108 infected cells. Immunoblot analysis of purified
wt and mutant dtCSB and HeLa WCE using antibodies against
CSB confirms the identity of the purified proteins (Fig. 1D, note
the slight increase in size of the dtCSB as compared with the
nontagged wt CSB in HeLa whole cell extract; for character-
ization of the antiserum, see Ref. 24).
Functionality of the Purified Recombinant dtCSB Protein in
Vivo—Prior to the biochemical characterization of the recom-
binant dtCSB protein, it was important to verify whether over-
production in the heterologous Baculo system and/or the puri-
fication procedure had not inactivated the biological function of
the protein, e.g. by improper folding or lack of post-transla-
tional modification.
One of the characteristic features of CS cells is their inability
to recover RNA synthesis after UV exposure (18, 35). To assess
the in vivo function of the recombinant wt CSB, the purified
protein was microinjected into the cytoplasm of living CS-B
(CS1AN) fibroblasts, and its ability to transiently correct the
DNA repair defect of CS-B cells was analyzed. The experimen-
tal protocol is outlined in Fig. 2A. CS1AN (CS-B) fibroblasts
were fused to generate homopolykaryons. After injection of at
least 50 multi-nucleated fibroblasts, the cells were irradiated
with 15J/m2 UV light and incubated for 16–20 h to allow
recovery from UV-induced inhibition of RNA synthesis. Tran-
scription was analyzed by a 1-h pulse labeling with [3H]uridine
followed by autoradiography. Transcription levels were quan-
tified by counting silver grains above the nuclei (10, 28). As
shown in Table II and Fig. 2B, in injected CS-B polykaryons the
recovery of UV-induced inhibition of transcription is resumed
to levels observed in wild-type cells assayed in parallel. In
contrast, the neighboring noninjected cells (monokaryons in
TABLE I
DNA substrates used as cofactors in ATPase assays and helicase templates
Helicase partial duplex templates were made by hybridyzing 59 32P-labelled F19 or F17 oligonucleotides to the F36 fragment.
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Fig. 2B), exhibit a very low level of transcription, which is
typical for UV-exposed CS-B fibroblasts.
When CSB was microinjected in CS-A and XP-B fibroblasts,
no significant complementation of their RNA-synthesis recov-
ery defect was observed, proving that the correcting activity is
specific for CS-B cells (Table II).
These experiments demonstrate that the purified recombi-
nant dtCSB protein is able to exert its biological function(s) in
vivo, including transportation to the nucleus and participation
in recovery of RNA synthesis, thus presumably also in tran-
scription-coupled repair and complex formation with RNA po-
lymerase II (24). The microinjection results confirm our earlier
findings with the transfected CS-B cells stably expressing the
dtCSB protein (24) and provide a solid basis for analysis of the
biochemical properties of the purified protein and its mutant
version.
In Vitro Biochemical Characterization of the Purified Recom-
binant wt and Mutant dtCSB Proteins—The presence of a
SNF2 domain in the CSB protein starting with a Walker A-type
nucleotide hydrolysis motif strongly suggested that CSB har-
bors an ATPase activity (21, 30). The mutant dtCSB (K538R)
protein should serve as an optimal negative control for this
assay. As shown in Fig. 3A, in the absence of nucleic acids, both
proteins exhibited a comparable background level of activity.
However, ATPase activity of wild-type dtCSB was highly stim-
ulated by the presence of ds l DNA in the reaction, in contrast
to the mutant protein (Fig. 3A). The extent of ATP hydrolysis
was proportional to the amount of wt dtCSB added to reactions
in which ATP concentration was kept constant and the DNA
cofactor was in excess (Fig. 3B and 5A). Quantification of ATP
hydrolysis showed that the conservative K538R substitution
resulted in a complete loss of the catalytic ATPase function of
CSB (Fig. 3B). Because wt and mutant proteins (purified in
parallel) are at the same level of purity and equally concen-
trated (Fig. 1C), this result indicates that DNA-dependent
ATPase activity is an intrinsic property of CSB protein and
that the K538R substitution abolishes ATP hydrolysis.
To get insight into the optimal structure of the DNA cofactor
FIG. 1. Purification of recombinant dtCSB. A, dtCSB purification scheme (see “Experimental Procedures”) and schematic representation of
the predicted functional domains of the CSB protein: A, acidic amino acid stretch; G, glycine-rich region; NLS, nuclear location signal. The lightly
shaded area represents the central CSB domain with overall high homology to the region shared between all members of the SNF2 family of
DNA-dependent ATPases. Roman numbers I–VI within this region refer to conserved “helicase” motifs that have been identified in numerous
known and putative DNA and RNA helicases. B, purification of recombinant wt dtCSB. Purification was monitored by SDS-PAGE. Aliquots of
samples at each purification step (for numbering of the corresponding steps see panel A) were analyzed on a 8% SDS-PAGE gel, and protein bands
were visualized by silver staining. (The faint staining at around 60 kDa is an artifact; see panel C). C, purified recombinant wild-type dtCSB and
dtCSB (K538R) mutant proteins. Aliquots of the last purification step (HA elutions) of both proteins (200 ng each) were resolved by SDS-PAGE
followed by silver staining. (The lane between the dtCSB samples is empty showing a faint staining artifact at the position of ;60 kDa). D,
immunoblot analysis of HeLa whole cell extract (WCE, 10 mg) and purified wt dtCSB and dtCSB (K538R). Affinity-purified anti-CSB polyclonal
antibodies were used (24). The positions of the molecular mass markers (MW) in kDa are shown.
Purification and Characterization of wt and Mutant CSB 11847
 at Erasm
us M
C M
edical Library on O
ctober 23, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
required for CSB ATPase activity, we tested several DNAs with
different structural properties for their ability to stimulate the
CSB ATPase. Various double-stranded DNAs, including ds l
DNA and supercoiled circular pBluescript DNA, elicited high
activity (Fig. 4C). Also M13 single-stranded DNA appeared a
potent activator (Fig. 4A, lane 1). Because dsDNA and ssDNA
are structurally very different, it is surprising that both stim-
ulate the CSB ATPase activity to a closely comparable extent.
Therefore we decided to premelt the M13 ssDNA to reduce
secondary structure. Fig. 4A shows that the stimulatory activ-
ity of M13 ssDNA was strongly decreased after boiling the
ssDNA followed by quenching on ice. These findings indicate
that unmelted M13 ssDNA is structurally ill defined and prob-
ably contains considerable double-stranded character. We con-
clude that the DNA structure is important for CSB ATPase
activity and that the protein is primarily stimulated by dsDNA.
To further investigate the substrate requirement of CSB, struc-
turally more defined oligonucleotides were tested for stimula-
tion of ATP hydrolysis by dtCSB. Using synthetic oligonucleo-
tides we observed that the presence of secondary structure such
as stem-loop and fork-like structures or DNA hairpins en-
hanced CSB ATPase activity (Fig. 4B and Table I), whereas
single-stranded molecules of the same length and sequence, as
well as RNA oligonucleotides and RNA/DNA hybrid molecules,
are only very weak activators (Fig. 5B and Table I). In this
respect, it is interesting to note the difference between the
activity elicited by a single-stranded poly-d(T).80 molecule
(Fig. 5B, open circles), which has little secondary structure, and
a single-stranded oligonucleotide containing palindromic se-
quences, which can give rise to stem-loop structures (Fig. 5B,
open triangles, for sequence see Table I). In addition, we ob-
served that CSB DNA-dependent ATPase activity was stimu-
lated to the same extent by both naked DNA and nucleosomal
DNA (Fig. 4C). Presence of MgCl2 was essential for catalytic
activity, which was optimal at a pH value of 7.5 and at 100 mM
salt (not shown).
Under the experimental conditions used, a turnover rate
ranging from 27 to 33 ATP min21 was calculated in the pres-
ence of dsDNA (Fig. 4B). The turnover number was calculated
in three independent experiments, including an ATPase kinet-
ics analysis with constant protein concentration and ds l DNA
in which ATP concentration ranged from 0.025 to 0.2 mM.
When ssDNA (poly(dT).80) was used as cofactor, the turnover
number was in the order of 3.7–6 ATP min21 (Fig. 4B).
In conclusion, our in vitro data indicate that CSB is a DNA-
dependent ATPase, which is specifically stimulated by double-
stranded DNA and double-stranded DNA structures with a
partial single-stranded character as well as nucleosomal DNA
but not by true ssDNA. Moreover, the conservative amino acid
substitution in the NTP binding motif impairs CSB ability of
FIG. 2. Assessment of recombinant wt dtCSB in vivo function
using microneedle injection. A, schematic representation of the
microinjection RNA-synthesis recovery assay. wt dtCSB protein (0.02–
0.05 mg/ml) purified from insect cells was injected into the cytoplasm of
CS-B fibroblasts (homopolykaryons were used for the injection). RNA
synthesis was assayed 16–20 h after UV irradiation by a 1-h pulse
labeling with [H3]uridine, fixation, and autoradiography (see “Experi-
mental Procedures” for details). B, micrograph of a CS-B binuclear
fibroblast (homopolykaryon) injected with wt dtCSB protein and as-
sayed for RNA synthesis recovery by autoradiography. The injected
binuclear CS-B cell (indicated by the arrow) exhibits a high level of
transcription, as indicated by the high number of silver grains above
both of its nuclei, whereas the noninjected surrounding CS-B fibro-
blasts (monokaryons) show the low level of RNA synthesis recovery
typical for UV-exposed CS cells.
FIG. 3. ATPase activity of recombinant wt and mutant dtCSB
protein. A, ATPase activity assay. Recombinant wt dtCSB and dtCSB
(K538R) proteins (15 ng) purified from Sf21 insect cells were assayed
for ATPase activity in the presence (1) or in the absence (2) of double-
stranded l DNA (150 ng) (see “Experimental Procedures”). Incubation
was for 30 min. B, effect of increasing dtCSB protein concentration on
ATP hydrolysis. Reactions were performed as in A in the presence or
absence of ds l DNA (150 ng) and the indicated protein concentration
for 30 min. Release of Pi was quantified using a PhosphorImager (Mo-
lecular Dynamics). l, wt dtCSB 1 l DNA; E, dtCSB (K538R) 1 lDNA;
, wt dtCSB and dtCSB (K538R) without DNA (data points are
superimposed).
TABLE II
Effect of microinjection of recombinant dtCSB protein on RNA
synthesis recovery
Cell strain
Comple-
mentation
group
Injected
proteina
UV
irradiation
Grains per
nucleus
Recovery
of RNA
synthesis
J/m2 mean 6
S.E.
% of
normalb
C5RO wt 15 69 6 3 100
C5RO wt wt-CSB 15 63 6 3 91
CS1AN CS-B 15 15 6 1 22
CS1AN CS-B wt-CSB 15 62 6 5 90
CS1AN CS-B K538R-CSB 15 26 6 2 38
GM2965 CS-A 15 20 6 1 29
GM2965 CS-A wt-CSB 15 22 6 2 32
C5RO wt 10 78 6 4 100
XPCS1BA XP-B 10 13 6 1 17
XPCS1BA XP-B wt-CSB 10 15 6 1 19
a Recombinant dtCSB protein purified from insect cells (see Fig. 1).
Estimated protein concentration, 0.02–0.05 mg/ml.
b As a control, basal transcription was also measured in unirradiated
cells. wt and CS1AN fibroblasts showed the same RNA synthesis level
under these experimental conditions: 123 6 4 grains/nucleus in wt
C5RO; 123 6 4 grains/nucleus in CS1AN.
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hydrolysing ATP, showing that ATPase activity is not due to a
contaminating polypeptide.
The highly conserved common domain of the family of SNF2/
SWI2 proteins shares significant homology with seven se-
quence motifs identified in numerous DNA and RNA helicases
that require NTP hydrolysis for disrupting the hydrogen bonds
that hold the two DNA strands together (for review see Refs. 36
and 37). To test whether functional dtCSB displayed any DNA
helicase activity, the protein was incubated with M13 ssDNA to
which a 32P-labeled 18- or 36-base primer was annealed. Re-
lease of the bound oligonucleotide from M13 DNA was analyzed
by polyacrylamide gel electrophoresis (see “Experimental Pro-
cedures”). Under the assay conditions used, which were able to
detect bona fide DNA helicase activity of purified TFIIH used
as positive control, no displacement of the helicase templates
was observed (not shown). Also, CSB failed to displace a 50-
base primer with a 15-nucleotide 39 or 59 noncomplementary
overhang (data not shown). The same negative results were
obtained with a 75-base double-stranded oligonucleotide and a
36-base oligonucleotide, to which a 59 32P-labeled 17-base or
19-base fragment (F17-F36; F19-F36; Table I) was annealed
(data not shown). Absence of detectable helicase activity in the
presence of DNA-dependent ATP-ase is in agreement with re-
cent findings reported by Selby and Sancar (34) using a non-
tagged, partially full-length CSB preparation.
Inactivation of the ATPase Activity Does Not Completely Im-
pair the in Vivo Function of CSB—As shown above, the specific
K538R substitution in the CSB nucleotide-binding domain
abolishes its catalytic ATPase activity in vitro. To investigate
the biological consequences of this mutation, purified dtCSB
(K538R) protein was microinjected into living CS-B fibroblasts
in parallel to injected wild-type dtCSB. The same type of mu-
tation (Lys to Arg) in the ATP hydrolysis domain of the dual
functional XPB DNA repair helicase was shown to possess a
dominant-negative in vivo effect; this mutant subunit of the
TFIIH repair/transcription complex completely paralyzes both
repair and basal transcription in a dominant fashion in normal
cells (28). Apparently, the mutant XPB protein is incorporated
in the TFIIH complex but is unable to exert its function,
thereby actively blocking both processes. The CSB protein too
is incorporated in a RNA polymerase II complex, and thus
substitution by an enzymatically dead molecule could actively
disrupt the processes in which it is engaged. However, in strik-
ing contrast to the effect of mutant XPB, injection of the re-
combinant dtCSB (K538R) protein even partially rescued the
defect in RNA synthesis recovery after UV irradiation in CS-B
fibroblasts (Table II). Although the activity is much lower when
compared with wt dtCSB, still a significant (approximately
2-fold) stimulation of resumption of transcription was observed
in repeated experiments (Table II). This partial in vivo activity
is in sharp contrast with the completely inactive ATP hydrol-
ysis of (K538R) mutant protein.
FIG. 4. Requirement of DNA cofactors for dtCSB ATPase ac-
tivity. A, secondary structure in M13 ssDNA is required for dtCSB
ATPase activity. wt dtCSB (10 ng) was assayed for ATP hydrolysis in
standard ATPase reactions (as in Fig. 3) containing the following DNA
molecules (150 ng): lane 1, M13 ssDNA; lane 2, M13 ssDNA premelted
at 95 °C and subsequently quenched on ice; lane 3, without DNA. B,
effect of different synthetic DNA molecules on dtCSB ATPase activity.
ATP hydrolysis by wt dtCSB (15 ng) was analyzed in the presence of
synthetic oligonucleotides with different secondary structures (150 ng):
lane 4, stem 19-loop 8; lane 5, stem 20-loop 15; lane 6, splayed arm; lane
7, single-stranded oligonucleotide (74 nucleotides); lane 8, oligo(dT)15; 9,
no DNA; 10 l DNA. See Table I for oligonucleotides sequences. C,
nucleosomal DNA acts as cofactor for CSB ATPase activity. wt dtCSB
ATPase activity was analyzed in the presence of naked and nucleosomal
DNA (150 ng): lane 11, l DNA; lane 12, double-stranded pBluescript
DNA; lane 13, bulk HeLa polynucleosomes; lane 14, without DNA.
FIG. 5. Kinetics of ATP hydrolysis. A, ATP hydrolysis as a function
of wt dtCSB protein concentration. Reactions contained 50 mM cold ATP
supplemented with 0.25 mCi of [g-32P]ATP (see “Experimental Proce-
dures”) and were incubated for 1 h at 30 °C. E, no DNA was added; l,
l DNA (150 ng) was added. B, ATP hydrolysis as a function of incuba-
tion time. wt dtCSB protein (35 ng) was assayed for ATP hydrolysis in
the presence of different nucleic acid cofactors (150 ng). Aliquots were
taken after incubation for 10, 20, 40, and 60 min and analyzed for
release of Pi. Reaction mixture contained synthetic oligonucleotides (74
nucleotides long): , ssDNA; , dsDNA; M, RNA; f, RNA-DNA hybrid;
E, poly(dT).80. See Table I for oligonucleotide sequences. The single-
stranded oligodeoxynucleotide described in Table I was annealed to its
complementary sequence and used as dsDNA cofactor. The synthetic
RNA oligonucleotide described in Table I was used either alone or
annealed to its complementary ssDNA oligonucleotide (RNA-DNA
hybrid).
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DISCUSSION
Purification of the dtCSB Protein Using Tags—Here we de-
scribe the successful isolation of double-tagged CSB protein
from baculovirus-infected SF21 cells. We have utilized a novel
purification procedure that has a number of advantages above
classical purification protocols: (i) The use of the HA and His6
tags allows a highly selective, rapid, standardized three-step
procedure. This avoids lengthy purification protocols involving
a large number of column chromatography steps. In independ-
ent experiments we have found that the HA-monoclonal affin-
ity chromatography by itself already can provide an .1000-fold
purification when starting from mammalian whole cell extracts
(38). The Ni21-nitrilotriacetic acid agarose column chromatog-
raphy specific for the hexameric histidine tag has the benefit
that it is very versatile because it can be carried out under a
wide range of conditions. (ii) The strategy used in this work has
also the advantage that it selects only for full-length protein
avoiding inclusion of partial degradation products in the final
purified protein preparation. (iii) The purification procedure is
very efficient: the dtCSB approach used yielded 22 mg of intact
CSB protein from 108 infected cells, appearing at least 15-fold
more efficient compared with classical protocols in which CSB
was successfully purified involving seven chromatographic
steps (34). A prerequisite for the use of tags is that one should
test whether the addition of tags interferes with the function of
the protein. In the case of dtCSB, we demonstrate in vivo and
in vitro that the tagged protein was fully functional. Microin-
jection and DNA transfection experiments showed that the
dtCSB protein completely corrected the defect in recovery of
UV-induced inhibition of RNA synthesis and UV sensitivity of
CS-B cells.
Biochemical Properties of the Purified dtCSB Protein—Puri-
fied wt dtCSB possesses an in vitro DNA-dependent ATPase
activity, as also reported recently by Selby and Sancar (34). We
investigated the DNA cofactor requirement for CSB ATPase
activity using structurally defined DNA substrates. The high-
est stimulation of CSB ATPase activity was observed when
dsDNA or structured oligonucleotides with a partial double-
and single-stranded character were used as DNA substrates
(Figs. 4B and 5B). Unexpectedly, M13 ssDNA also exerts a
strong stimulation. The notion that true dsDNA and ssDNA
are physicochemically very different rendered it unlikely that
both should be equally efficient in enhancing CSB-ATPase.
However, the ATPase stimulation by M13 ssDNA was drasti-
cally reduced after removing secondary structure by melting.
This indicates that the double-stranded character in M13
ssDNA was responsible for the stimulation and that true
ssDNA is a poor activator for CSB ATPase. This was confirmed
by the use of poly(dT).80, which is known to have little second-
ary structure and “single-stranded” oligonucleodides with mul-
tiple palindromic sequences. In addition to differences in pro-
tein preparations, the above observation may explain the
findings of Selby and Sancar, who reported a strong stimula-
tion of CSB-ATPase by ssDNA (34) and the yeast equivalent
RAD26, which was reported by Guzder et al. to be stimulated
preferentially by ssDNA (39). In fact, for any ssDNA-dependent
ATPases for which nonpremelted ssDNA substrates were used,
it should be considered a possibility that the stimulation was
not derived from ssDNA but from double-stranded structures
within it. The fact that the CSB ATPase activity is strongly
enhanced by ds/ss DNA substrates such as Y-structures con-
taining hairpins opens the possibility that a double-stranded to
single-stranded transition is a biological relevant DNA confor-
mation for CSB. In addition, we find that ATP hydrolysis by
CSB is stimulated equally by naked dsDNA and nucleosomal
DNA (Fig. 4C). A similar observation is made for the ySWIzSNF
complex (40, 41). Specific activity of dtCSB in the presence of
dsDNA was approximately 160 pmol ADP formed/mg CSB/min
(Kcat 5 ;27 min
21), which is within the range of activities
measured for other DNA-dependent ATPases of the same fam-
ily. In particular, CSB appears to be a stronger ATPase than
the recombinant ySNF2 (20 pmol ADP/mg/min (42)) as well as
the Drosophila NURF complex (Kcat 5 ;8.5 min
21 in the
presence of nucleosomal DNA) (43).
As observed with other members of the SNF2-like family of
ATPases, no overt helicase activity could be attributed to CSB,
using classical helicase DNA substrates as well as DNA mole-
cules with different types of noncomplementary overhangs (39,
42). The high homology of CSB with members of the SNF2
family suggests that these proteins may function via a similar
mechanism. SNF2-like proteins have been reported to be in-
volved in chromatin remodelling and to be able to disrupt
protein-DNA interactions (44–47). On this basis, it has been
proposed that they function as DNA-translocating factors that
use the energy derived from ATP hydrolysis to move along the
DNA, destabilizing proteins bound to the DNA (48). Similarly,
we can speculate that CSB uses energy from ATP hydrolysis to
induce some type of structural alteration in the DNA, involving
local strand separation that diminishes the affinity of bound
protein for dsDNA. It has been shown that NTP-binding pro-
teins undergo conformational changes upon NTP binding and
hydrolysis. Recently, a structural homology was found between
a DNA helicase of Bacillus stearothermophilus and the recom-
bination protein RecA. This suggested a common basis for the
coupling of ATP binding/hydrolysis to conformational changes
of the protein, affecting the affinity of the enzyme for different
DNA substrates, thereby driving the catalytic reaction (49). In
agreement with this idea we recently found CSB to reside in a
large MW complex in vivo. This complex contains RNA polym-
erase II but is devoid of transcription initiation factors (24), and
its further characterization indicates that it most likely repre-
sents an elongation mode of RNA polymerase II.2 Direct in vitro
association of CSB with RNA polymerase II was reported re-
cently by Tantin et al. (50) and by Selby and Sancar (51). The
latter study also provided evidence that CSB stimulates tran-
scription elongation in vitro. The DNA structure requirements
of CSB presented here are consistent with the transitions from
ssDNA to dsDNA at the site of an elongating or stalled RNA
polymerase. At this location the CSB protein may help desta-
bilize nucleosome-DNA interactions, thus facilitating tran-
scription elongation at pause sites. In addition, CSB may en-
able resumption of stalled transcription elongation after DNA
damage removal by dissociating NER (such as TFIIH) and
other repair factors and/or nucleosomes bound to the DNA.
Biological Consequences of ATPase Deficiency on the Func-
tioning of CSB—By site-directed mutagenesis the invariant
lysine 538 residue in CSB ATP binding motif was replaced with
the physicochemically related arginine. The conservative
K538R mutation leads to a (virtual) complete loss of dtCSB
ATPase activity in vitro (Fig. 3, A and B), as also has been
shown for a variety of other ATPases (31, 42, 52). Surprisingly,
we found that the ATPase-dead CSB protein still exerts a
partial function in vivo, as shown by microinjection experi-
ments in CS-B fibroblasts (Table II). Interestingly, the in vivo
results suggest that this specific mutation can partially uncou-
ple ATP hydrolysis from other biological activities of CSB,
implying that other properties of CSB are also important for its
function. In this respect is relevant to note that CS-B cell line
(CS1AN) used in this study carries two alleles, each leading to
a severely truncated CSB protein product (18). In fact, system-
2 E. Citterio and J. H. J. Hoeijmakers, unpublished observations.
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atic mutation analysis of a large number of CSB patients has
revealed that most patients produce severe CSB truncations.
Our microinjection experiments suggest that having an enzy-
matically dead but physically intact CSB molecule is still better
than having no protein at all. We suggest that the partial
activity observed may be due to the fact that the enzymatically
inactive CSB mutant protein may help stabilize a CSB-contain-
ing complex or otherwise permits this complex to function
better when CSB is physically present. In fact, this is very
similar to findings made with a comparable Lys to Arg substi-
tution in the XPD helicase of TFIIH.3 For the transcription
function of the TFIIH complex, this protein must be physically
present to permit complex formation or stability, but it does not
have to be enzymatically functioning. For the NER function of
the TFIIH complex, the XPD helicase activity is at least in part
required. Also for other protein complexes it has been shown
that absence of one subunits leads to instability of the complex
(e.g. Ref. 53). Consistent with the above interpretations for the
partial activity of mutant CSB is the notion that the conserv-
ative Lys to Arg amino acid substitution is not expected to
dramatically alter the overall structure of the CSB protein.
Because we observe a biological effect, the dtCSB (K538R)
mutant protein probably still fits into the RNA polymerase II
complex. Our finding that the same type of amino acid substi-
tution in the XPB and XPD helicase subunits of TFIIH exerts
at least some biological effects strongly suggests that also these
mutant proteins are still capable of complex formation. The
intriguing finding that an enzymatically inactive CSB protein
still exert some function in vivo supports the idea that inter-
action of CSB with other transcription/repair proteins per se
contributes to its function(s).
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